genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
29 March 2018
21 March 2018 Capital Networks - Note on Genedrive's Interim Results
View all reports >
Tuesday May 15, 2018
Genedrive to sell contract research and pharmacogenomics divisions for up to £1.9mln
Tuesday April 10, 2018
Genedrive has Hepatitis C test performance data published in leading medical journal
Tuesday April 03, 2018
Genedrive to premiere Hepatitis C test at Asia-Pacific medical exhibition
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-18 genedrive plc
Don't show this again